GlobeNewsWire
02 Jun 2026, 11:40 UTC · 2h ago
Search tags
Story key points
1 claims · impact-rated
Quantum BioPharma has entered into a 6-month investor relations and marketing agreement with IR Agency LLC for a fee of US$250,000. — While the move aims to increase investor awareness and lead generation, IR agreements are common and do not fundamentally change the company's clinical or financial health.
+0.10Ticker attribution
Model heads
The company is initiating a strategic investor relations and marketing campaign to increase visibility and lead generation.
No ticker relationship head found.
Early access
News Impact Screener scores every headline against the stocks it moves — before the chart reacts. Join the early-access list and get alerted the moment a story hits your tickers.
Impact vectors
Continue reading
6 related stories
0 dimensions · 9 clusters
No impact vector found for this article yet.
Market reaction
0 bid · 0 offered
No stock impact ranking available yet.
No stock impact ranking available yet.
Business Wire
3h ago
